2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Stomach Neoplasms
5
Colorectal Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Keratoacanthoma familial
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Desmoid Tumors
1
Dermoid Cyst
1
Carcinoma, Non-Small-Cell Lung
1
Camurati-Engelmann Syndrome
1
Anemia
1
Interventions
vactosertib
1
Salpingo-oophorectomy
1
Saline Solution
1
Magnetic Resonance Imaging
1
Lidocaine
1
Imatinib Mesylate
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dermoid Cyst
×
vactosertib
×
Clear all
NCT06219733
2024-12-09
MP-VAC-206
MedPacto, Inc.
Phase 2
Withdrawn